Mining Electronic Health Records: Challenges and Impact
暂无分享,去创建一个
Ernestina Menasalvas Ruiz | Alejandro Rodríguez González | Consuelo Gonzalo | A. R. González | Consuelo Gonzalo
[1] S Morin-Ben Abdallah,et al. Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? , 2018, Current oncology.
[2] Gang Chen,et al. CEP72‐ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next‐generation sequencing , 2018, Thoracic cancer.
[3] Geoffrey R. Oxnard,et al. Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer , 2013, Science Translational Medicine.
[4] J. Engelman,et al. ALK in lung cancer: past, present, and future. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] T. Arakawa,et al. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system , 1997, Oncogene.
[6] Olivier Bodenreider,et al. The Unified Medical Language System (UMLS): integrating biomedical terminology , 2004, Nucleic Acids Res..
[7] J. Shih,et al. Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer , 2018, Molecular Cancer.
[8] M. Tamburini,et al. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. , 1996, European journal of cancer.
[9] Yoshihiko Hayashi,et al. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report , 2018, The Journal of international medical research.
[10] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[11] David A. Ferrucci,et al. UIMA: an architectural approach to unstructured information processing in the corporate research environment , 2004, Natural Language Engineering.
[12] E. McFadden,et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.
[13] N. Ridgway,et al. Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. , 2011, Journal of thoracic disease.
[14] Kent A. Spackman,et al. SNOMED RT: a reference terminology for health care , 1997, AMIA.
[15] H. Aburatani,et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer , 2007, Nature.
[16] B. Chan,et al. Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. , 2015, Translational lung cancer research.
[17] L. Sequist,et al. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. , 2015, The Lancet. Oncology.